Negative Points

• Total revenue declined approximately 1% sequentially in Q2, driven by seasonality in legacy payment processing revenue due to the reset of health plan deductibles.

• The company is moderating subscription pricing to support providers facing economic strain, which could pressure subscription revenue growth in the near term.

• Management noted a lack of visibility in Network Solutions earlier in the year, and while progress has been made, there is still uncertainty in this segment's revenue contribution.

• The company faces intense competition from EHR vendors offering check-in management solutions, which could impact its ability to grow its client base.

• Phreesia Inc ( NYSE:PHR ) is maintaining its adjusted EBITDA guidance despite strong Q2 performance, citing the need for prudence around revenue mix, AI investments, and potential growth opportunities.

• The company's revenue mix is expected to fluctuate, with a shift toward payments and network solutions, which may create variability in revenue per client and complicate financial modeling.

• Macro trends in patient volumes and deductible reset patterns showed some weakness earlier in the year, though nothing notable was reported in Q2.

Q & A Highlights

Q: Can you provide an update on the progress of integrating AccessOne and selling its financing solutions to your existing client base, particularly those that are not investment-grade? A: Balaji Gandhi (CFO) and Chaim Indig (CEO) expressed increased confidence in the AccessOne acquisition since closing. They are seeing early wins in the market and receiving very positive feedback from existing clients on the offering. The securitization facility expansion has enabled them to offer upfront funding to a broader segment of the market, and they view AccessOne as a significant growth lever over the next couple of years.

Q: What are you seeing in the Network Solutions business, particularly in areas where you previously had a lack of visibility? Has anything changed? A: Balaji Gandhi (CFO) noted that while total revenue is in line with expectations, they have seen significant progress in the second half of the year regarding Network Solutions business activity. New products like Provider Connect are resonating well with the market, and the team has done an excellent job, leaving them encouraged about the current trajectory compared to 90 or 180 days ago.

Q: You mentioned a successful GLP-1 campaign that generated positive ROI. Did this pilot convert into any follow-on contracts or expanded opportunities? A: Balaji Gandhi (CFO) confirmed that the successful GLP-1 campaign did help convert new business activity and contributed to the positive momentum in the Network Solutions segment, directly relating to the progress mentioned in the previous answer.

Q: How are you navigating the competitive dynamics with EHRs that offer their own check-in management solutions, and are your new sales occurring in providers whose EHR does not offer this? A: Balaji Gandhi (CFO) clarified that this competitive dynamic has been a normal part of the landscape for the company's entire history, not a new change. He emphasized that Phreesia differentiates itself through its product, go-to-market strategy, and client relationships. The company leans into different markets based on the economic profile of the client, and there is nothing new to report regarding the competitive environment.

Q: Can you provide more detail on the pricing strategy for your subscription offering, given the deliberate effort to moderate price increases to encourage downstream revenue? How should we model this line item for the remainder of the year? A: Chaim Indig (CEO) explained that providers are under significant economic strain due to changes in payer dynamics, and Phreesia aims to be a great partner by providing as much value as possible during this time. Balaji Gandhi (CFO) added that this approach is similar to their strategy during the pandemic, which yielded positive results. He advised that while some revenue in the second half may shift out of subscription and into Network Solutions, the total revenue outlook remains unchanged.

Q: How are you thinking about expanding your product strategy into areas like prior authorization, given the financial strain on providers? Is there a way to monetize this directly? A: Chaim Indig (CEO) highlighted that their front-end revenue cycle tools, such as Plan Match and eligibility verification, have been wildly well-received by clients. While declining to comment on specific new products, he stated they are doubling down on their commitment to providing providers with tools that help them run their practices efficiently. Balaji Gandhi (CFO) added that the AccessOne acquisition was a direct extension of this strategy to address the broader revenue cycle needs of providers.

Q: How are you thinking about injecting AI functionality into your payment offerings to drive greater patient engagement? A: Chaim Indig (CEO) stated that AI is being embraced across the organization and has had a meaningful impact on all aspects of operations, from product development to sales. He cited new products like voice AI and Plan Match as examples of AI-driven innovations that were previously unimaginable. He expressed that AI has changed the playing field, making him more excited about the company's opportunity set than ever before, and believes it positions Phreesia to potentially accelerate its growth in the future.

Q: Given another solid quarter of EBITDA performance, why did you decide to maintain the EBITDA guidance for the fiscal year? A: Balaji Gandhi (CFO) cited a host of factors, including disciplined expense management and a focus on return on investment. He noted that the company wants to leave room for growth investments, and the revenue mix is a sensitive component. Additionally, he mentioned that AI deployment is still in its early innings, and the company is being prudent about how it shares information related to this dynamic and fluid time.

Q: As you moderate subscription pricing to drive downstream payments and network growth, how are retention and attach rates evolving, and how should we think about the long-term mix shift in revenue per client? A: Balaji Gandhi (CFO) reiterated that the company holistically thinks about total revenue and total revenue per client. He stated that the mix between subscription, payments, and network revenue will fluctuate, which is a sign of the diversity of their business model. The company will continue to communicate with investors about total revenue and will try to get in front of any significant mix shifts.

Q: Can you provide any color on macro trends in patient volumes and the pace at which patients are getting through their deductibles in the back half of the fiscal year? A: Balaji Gandhi (CFO) stated that while they look at this data carefully and do a lot of trending, there was nothing notable to call out in the second quarter regarding volume trends or deductible reset trends. Earlier in the year, they had noted a little more weakness beyond typical seasonality, but that has not persisted into the second quarter.

For the complete transcript of the earnings call, please refer to the full earnings call transcript .